Literature DB >> 14605149

Application of an rRNA probe matrix for rapid identification of bacteria and fungi from routine blood cultures.

Elizabeth M Marlowe1, James J Hogan, Janet F Hindler, Irene Andruszkiewicz, Pat Gordon, David A Bruckner.   

Abstract

One of the most important functions of the clinical microbiology laboratory is the identification of the etiology of sepsis. For this study, aliquots from 405 positive blood cultures were tested against a unique array of DNA probes directed against rRNA subsequences of bacteria and fungi for identification. Another 280 samples that were negative after 5 days of incubation were also tested. Blood culture bottles were incubated in a BacT/Alert3D instrument. For the rRNA assay, a 0.4-ml aliquot was removed, and the cells were pelleted by centrifugation. The pellet was washed and frozen at -70 degrees C. Analysis of the pellet involved a lysis step and then the addition of samples to the reaction wells containing the probes in a microtiter plate format. Analysis was performed by using a hybridization protection assay. Results were taken through a series of deductive steps to obtain species, or in some cases genus, identification. Batch sample preparation required approximately 15 min, and sample analysis required another 60 min. Probe results were compared to conventional biochemical identifications. The probe test was negative for the 280 samples that were negative by the BacT/Alert 3D system and for another 21 samples that were false positive (the instrument signaled, but there was no growth). Microorganisms from the remaining 384 signal-positive samples included 60 Enterobacteriaceae, 10 Pseudomonas aeruginosa, 10 other gram-negative bacteria, 40 Staphylococcus aureus, 152 coagulase-negative staphylococci, 28 streptococci, 22 enterococci, 21 other gram-positive bacteria, 8 anaerobes, and 16 yeast organisms. Seventeen cultures were polymicrobial, and one was gram positive and culture negative. Discordance between probe and conventional identification results was noted for only 12 (1.75%) samples. This novel rapid molecular approach to the identification of bacteria and yeast in blood cultures was highly sensitive (100%) and specific (96%).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605149      PMCID: PMC262507          DOI: 10.1128/JCM.41.11.5127-5133.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures.

Authors:  V A Kempf; K Trebesius; I B Autenrieth
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes.

Authors:  G J Jansen; M Mooibroek; J Idema; H J Harmsen; G W Welling; J E Degener
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management.

Authors:  Erik L Munson; Daniel J Diekema; Susan E Beekmann; Kimberle C Chapin; Gary V Doern
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

4.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Comparison of DNA probe technology and automated continuous-monitoring blood culture systems in the detection of neonatal bacteremia.

Authors:  D Hertz; D Fuller; T Davis; L Papile; D Stevenson; J Lemons
Journal:  J Perinatol       Date:  1999-06       Impact factor: 2.521

6.  Multiplex PCR for detection of Enterobacteriaceae in blood.

Authors:  K Sen; D M Asher
Journal:  Transfusion       Date:  2001-11       Impact factor: 3.157

7.  Rapid identification of methicillin-resistant Staphylococcus aureus from positive blood cultures by real-time fluorescence PCR.

Authors:  T Y Tan; S Corden; R Barnes; B Cookson
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

8.  Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes.

Authors:  Kenneth Oliveira; Gary W Procop; Deborah Wilson; James Coull; Henrik Stender
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components.

Authors:  M E Brecher; D G Heath; S N Hay; S J Rothenberg; L C Stutzman
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

10.  Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood cultures.

Authors:  K Maquelin; C Kirschner; L-P Choo-Smith; N A Ngo-Thi; T van Vreeswijk; M Stämmler; H P Endtz; H A Bruining; D Naumann; G J Puppels
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  15 in total

1.  Evaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood cultures.

Authors:  U Eigner; M Weizenegger; A-M Fahr; W Witte
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice.

Authors:  Remco P H Peters; Paul H M Savelkoul; Alberdina M Simoons-Smit; Sven A Danner; Christina M J E Vandenbroucke-Grauls; Michiel A van Agtmael
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-lactamase from positive blood culture bottles by PCR followed by microchip gel electrophoresis.

Authors:  Shin-ichi Fujita; Kentaro Yosizaki; Thikako Ogushi; Kouhei Uechi; Yukiko Takemori; Yasuko Senda
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

Review 4.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Early identification of sepsis.

Authors:  Mateus Demarchi Gonsalves; Yasser Sakr
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

6.  Multicenter evaluation of a new shortened peptide nucleic acid fluorescence in situ hybridization procedure for species identification of select Gram-negative bacilli from blood cultures.

Authors:  Margie Morgan; Elizabeth Marlowe; Phyllis Della-Latta; Hossein Salimnia; Susan Novak-Weekley; Fann Wu; Benjamin S Crystal
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

7.  Sensitivity and specificity of a rapid rRNA gene probe assay for simultaneous identification of Staphylococcus aureus and detection of mecA.

Authors:  Shannon Kaplan; Elizabeth M Marlowe; James J Hogan; Mehmet Doymaz; David A Bruckner; Andrew E Simor
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 8.  Molecular microbiological methods in the diagnosis of neonatal sepsis.

Authors:  Mohan Venkatesh; Angela Flores; Ruth Ann Luna; James Versalovic
Journal:  Expert Rev Anti Infect Ther       Date:  2010-09       Impact factor: 5.091

9.  Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray.

Authors:  Berit E E Cleven; Maria Palka-Santini; Jörg Gielen; Salima Meembor; Martin Krönke; Oleg Krut
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 10.  [Molecular biological detection of pathogens in patients with sepsis. Potentials, limitations and perspectives].

Authors:  K-P Hunfeld; T Bingold; V Brade; H Wissing
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.